Huang, Hung-LingHung-LingHuangMENG-RUI LEECheng, Meng-HsuanMeng-HsuanChengLu, Po-LiangPo-LiangLuHuang, Chun-KaiChun-KaiHuangSheu, Chau-ChyunChau-ChyunSheuLai, Ping-ChangPing-ChangLaiChen, Tun-ChiehTun-ChiehChenJANN-YUAN WANGChong, Inn-WenInn-WenChong2021-11-032021-11-03202110584838https://scholars.lib.ntu.edu.tw/handle/123456789/586159Weekly rifapentine and isoniazid (3HP) is gaining popularity for latent tuberculosis infection treatment because of its short course and high completion rate. Prior to widespread use, comprehensive 3HP treatment assessment covering an all-age population is essential.enage; hypertension; latent tuberculosis infection; rifapentine; systemic drug reaction[SDGs]SDG3acyltransferase; alanine aminotransferase; angiotensin receptor antagonist; antihypertensive agent; aspartate aminotransferase; beta adrenergic receptor blocking agent; bilirubin; calcium channel blocking agent; cytokine; dipeptidyl carboxypeptidase inhibitor; diuretic agent; generic drug; isoniazid; paracetamol; rifapentine; isoniazid; rifampicin; rifapentine; tuberculostatic agent; adult; age; aged; alanine aminotransferase blood level; antihypertensive therapy; arthralgia; Article; aspartate aminotransferase blood level; atopy; bilirubin blood level; blood pressure; case report; chill; chronic kidney failure; clinical article; comorbidity; confidence interval; congestive heart failure; conjunctivitis; coronary artery disease; dementia; diabetes mellitus; diabetic patient; diarrhea; dizziness; drug withdrawal; dyspnea; female; fever; flu like syndrome; follow up; gastrointestinal symptom; headache; health care personnel; heart palpitation; hepatitis B; hepatitis C; high risk population; household; human; hypertension; hypotension; laboratory test; latent tuberculosis; lethargy; liver function; liver toxicity; malaise; male; malignant neoplasm; middle aged; multivariate logistic regression analysis; myalgia; nursing home patient; pathophysiology; peptic ulcer; postmarketing surveillance; risk factor; school; skin manifestation; smoking; symptom; thorax radiography; treatment duration; treatment interruption; treatment outcome; upper respiratory tract; urticaria; workplace; young adult; combination drug therapy; latent tuberculosis; Aged; Antitubercular Agents; Drug Therapy, Combination; Humans; Isoniazid; Latent Tuberculosis; Middle Aged; Rifampinjournal article10.1093/cid/ciaa1741332151872-s2.0-85107911985https://api.elsevier.com/content/abstract/scopus_id/85107911985